Chambers C, Chitwood B, Smith C, Miao Y
iRadiology. 2024; 2(2):128-155.
PMID: 38708130
PMC: 11067702.
DOI: 10.1002/ird3.62.
Obeid K, Kanellopoulos P, Abouzayed A, Mattsson A, Tolmachev V, Nock B
Pharmaceutics. 2024; 16(4).
PMID: 38675174
PMC: 11054746.
DOI: 10.3390/pharmaceutics16040513.
Nock B, Kanellopoulos P, Joosten L, Mansi R, Maina T
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242457
PMC: 10222684.
DOI: 10.3390/ph16050674.
Mansi R, Nock B, Dalm S, Busstra M, van Weerden W, Maina T
Cancers (Basel). 2021; 13(22).
PMID: 34830920
PMC: 8616220.
DOI: 10.3390/cancers13225766.
Kaloudi A, Lymperis E, Kanellopoulos P, Waser B, de Jong M, Krenning E
Pharmaceuticals (Basel). 2019; 12(1).
PMID: 30897789
PMC: 6469168.
DOI: 10.3390/ph12010042.
Comparing Gly/dAla-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the In-SB3/In-SB4 Radiotracer Pair.
Lymperis E, Kaloudi A, Kanellopoulos P, de Jong M, Krenning E, Nock B
Molecules. 2019; 24(6).
PMID: 30871262
PMC: 6471467.
DOI: 10.3390/molecules24061015.
NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.
Kaloudi A, Lymperis E, Giarika A, Dalm S, Orlandi F, Barbato D
Molecules. 2017; 22(11).
PMID: 29137110
PMC: 6150197.
DOI: 10.3390/molecules22111950.
Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice.
Inan S, Dun N, Cowan A
Peptides. 2010; 32(2):286-92.
PMID: 21126550
PMC: 3995915.
DOI: 10.1016/j.peptides.2010.11.022.
Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat.
Mountney C, Anisman H, Merali Z
Psychopharmacology (Berl). 2008; 200(1):51-8.
PMID: 18563394
DOI: 10.1007/s00213-008-1118-7.
International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.
Jensen R, Battey J, Spindel E, Benya R
Pharmacol Rev. 2007; 60(1):1-42.
PMID: 18055507
PMC: 2517428.
DOI: 10.1124/pr.107.07108.
Targeting prostate cancer with radiolabelled bombesins.
Maina T, Nock B, Mather S
Cancer Imaging. 2006; 6:153-7.
PMID: 17098646
PMC: 1693771.
DOI: 10.1102/1470-7330.2006.0025.
The role of gastrin-releasing peptide on conditioned fear: differential cortical and amygdaloid responses in the rat.
Mountney C, Sillberg V, Kent P, Anisman H, Merali Z
Psychopharmacology (Berl). 2006; 189(3):287-96.
PMID: 17033843
DOI: 10.1007/s00213-006-0585-y.
Characterization of scratching responses in rats following centrally administered morphine or bombesin.
Lee H, Naughton N, Woods J, Ko M
Behav Pharmacol. 2003; 14(7):501-8.
PMID: 14557717
PMC: 1810379.
DOI: 10.1097/01.fbp.0000095082.80017.0f.
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Welsh J, Sapinoso L, Kern S, Brown D, Liu T, Bauskin A
Proc Natl Acad Sci U S A. 2003; 100(6):3410-5.
PMID: 12624183
PMC: 152306.
DOI: 10.1073/pnas.0530278100.
Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
Gugger M, Reubi J
Am J Pathol. 1999; 155(6):2067-76.
PMID: 10595936
PMC: 1866930.
DOI: 10.1016/S0002-9440(10)65525-3.
